Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD
- 1 May 2002
- Vol. 121 (5) , 1449-1455
- https://doi.org/10.1378/chest.121.5.1449
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitisEuropean Respiratory Journal, 2001
- The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991Respiratory Medicine, 2000
- Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysemaRespiratory Medicine, 2000
- Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPDChest, 1999
- Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1999
- Treatment of chronic obstructive pulmonary disease and its exacerbations in general practiceRespiratory Medicine, 1999
- Obstructive Lung Disease Deaths in the United States from 1979 through 1993American Journal of Respiratory and Critical Care Medicine, 1997
- The Effect of Diabetes mellitus on the Outcome of Patients with Chronic Obstructive Pulmonary Disease Exacerbated due to Respiratory InfectionsRespiration, 1996
- Cost management in community-acquired lower respiratory tract infectionThe American Journal of Medicine, 1995
- Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the communityThe Lancet, 1993